Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease — VASCADE  

Common Femoral Artery Stenosis Clinical Trial

Official title: Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With Common Femoral Artery Disease: A Retrospective Comparison Study

Status Completed

Clinical Trial Summary

To study the patient characteristics and outcomes associated with the real-world use of manual compression vs. vascular closure devices (VCDs) after common femoral artery (CFA) percutaneous access for coronary and endovascular interventions. An institutional procedural database, based on electronic medical record information will be abstracted to collect this information.

Clinical Trial Description

The overall objective of the study will be to examine the safety and efficacy of the VASCADE closure device compared to manual compression (standard of care) to achieve hemostasis after endovascular procedures requiring access within a severely diseased CFA. This study will be a retrospective single center review of 200 patients undergoing endovascular procedures utilizing vascular access within a severely diseased CFA between 2018 and 2020 at Yale New Haven Hospital. A random selection of patients undergoing hemostasis with manual compression (n = 100) and VASCADE vascular closure system (n = 100) will be conducted. The two groups will then be statistically compared with respect to 48-hour and 30-day safety and efficacy outcomes. ;

Related Conditions & MeSH terms

• Common Femoral Artery Stenosis

• NCT number: NCT04745624
• Study type: Observational
• Source: Yale University
• Status: Completed
• Start date: August 20, 2020
• Completion date: December 1, 2021